LENSAR, Inc. Common Stock (LNSR) Stock Price

LNSRStock

$5.80−50.93%52W

Market Cap$71.26M

P/E—

PEG Ratio—

Div yield—

Beta1.02

LNSR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-13.88%

Price vs S&P 500 (4W)-18.23%

VGM Score60.34

Book Value / Share (Quarterly)$2.34

P/TBV (Annual)8.73x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)18.23%

Cash Flow / Share (Quarterly)$-0.60

Price vs S&P 500 (YTD)-62.06%

Gross Margin (TTM)46.43%

Net Profit Margin (TTM)57.57%

EPS (TTM)$2.08

10-Day Avg Trading Volume0.04M

EPS Excl Extra (TTM)$2.08

Revenue Growth (5Y)17.24%

EPS (Annual)$-2.87

ROI (Annual)-165.28%

Gross Margin (Annual)46.41%

Net Profit Margin (5Y Avg)-52.93%

Cash / Share (Quarterly)$1.10

P/E Basic Excl Extra (TTM)2.05x

Revenue Growth QoQ (YoY)18.37%

ROA (Last FY)-47.58%

Revenue Growth TTM (YoY)3.26%

EBITD / Share (TTM)$0.18

ROE (5Y Avg)-61.69%

Operating Margin (TTM)3.11%

Cash Flow / Share (Annual)$-0.20

P/B Ratio2.48x

P/B Ratio (Quarterly)2.44x

Net Income / Employee (Annual)$-228,500

EV / Revenue (TTM)0.96x

Net Interest Coverage (TTM)-14.33x

ROA (TTM)50.03%

EV / EBITDA (TTM)20.68x

EPS Incl Extra (Annual)$-2.87

Current Ratio (Annual)2.80x

Quick Ratio (Quarterly)1.03x

3-Month Avg Trading Volume0.10M

52-Week Price Return-50.93%

P/E Incl Extra (TTM)2.05x

Revenue / Employee (TTM)$401,800

Tangible BV / Share (Quarterly)$1.95

P/S Ratio (Annual)1.22x

Asset Turnover (Annual)0.81x

52-Week High$12.94

Operating Margin (5Y Avg)-41.02%

EPS Excl Extra (Annual)$-2.87

CapEx CAGR (5Y)-25.84%

26-Week Price Return-3.97%

Quick Ratio (Annual)1.97x

13-Week Price Return0.00%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.39x

Enterprise Value$57.69M

Revenue / Share Growth (5Y)-3.07%

Asset Turnover (TTM)0.87x

Revenue / Employee (Annual)$389,600

Inventory Turnover (Annual)2.05x

Pretax Margin (Annual)-58.66%

Cash / Share (Annual)$1.83

3-Month Return Std Dev77.71%

Gross Margin (5Y Avg)50.60%

Net Income / Employee (TTM)$231,300

ROE (Last FY)-165.28%

EPS Basic Excl Extra (Annual)$-2.87

Receivables Turnover (TTM)10.80x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$2.08

Receivables Turnover (Annual)7.65x

ROI (TTM)149.70%

P/S Ratio (TTM)1.18x

Pretax Margin (5Y Avg)-52.93%

Revenue / Share (Annual)$4.89

Tangible BV / Share (Annual)$0.99

Forward P/E164.88x

Price vs S&P 500 (52W)-66.46%

P/E Ratio (TTM)2.05x

Year-to-Date Return-50.13%

5-Day Price Return-6.75%

EPS Normalized (Annual)$-2.87

ROA (5Y Avg)-31.65%

Net Profit Margin (Annual)-58.66%

Month-to-Date Return-11.99%

Cash Flow / Share (TTM)$-0.87

EBITD / Share (Annual)$-1.98

Operating Margin (Annual)-42.06%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-61.69%

P/E Excl Extra (TTM)2.05x

LT Debt / Equity (Quarterly)0.20x

EPS Basic Excl Extra (TTM)$2.08

P/TBV (Quarterly)2.93x

P/B Ratio (Annual)5.77x

Inventory Turnover (TTM)1.46x

Pretax Margin (TTM)57.57%

Book Value / Share (Annual)$1.50

Price vs S&P 500 (13W)-2.69%

Beta1.02x

Revenue / Share (TTM)$2.62

ROE (TTM)149.70%

52-Week Low$4.95

vGradeB

gGradeC

mGradeC

vgmGradeB

LNSR Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$0.27	$0.10	+137.07%(+$0.37)
Q1 2026	May 8, 2026	$0.49	-$0.20	-140.08%(-$0.69)
Q4 2025	Mar 31, 2026	-$0.10	-$0.11	-7.77%(-$0.01)
Q3 2025	Nov 6, 2025	-$0.08	-$0.11	-37.25%(-$0.03)
Q2 2025	Aug 7, 2025	-$0.07	-$0.10	-29.07%(-$0.02)

LNSR Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.25

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
LNSRLENSAR, Inc. Common Stock	B	C	C	1.2x	17.2%	46.4%	3.1%	$5.80
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About LENSAR, Inc. Common Stock

LENSAR Inc develops and commercializes femtosecond laser systems for cataract surgery. The company's proprietary technology platform provides surgeons with advanced imaging, simplified procedure planning, and precision capabilities to enhance surgical outcomes and procedural efficiency. LENSAR generates revenue through its core laser system and associated consumable components, creating a recurring revenue model.

LNSR Next Earnings Report

Report dateNov 12, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$0.14

Revenue estimate$14.30M

Also reporting on Nov 12, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

STEXStreamex Corp. Common StockElectromedical Equipment
HYPRHyperfine, Inc. Class A Common StockElectromedical Equipment
NTRBNutriband Inc. Common StockOrthopedic & Prosthetic Devices
OMOutset Medical, Inc. Common StockElectromedical Equipment
ECORelectroCore, Inc. Common StockElectromedical Equipment
OPXSOptex Systems Holdings, INCOptical Instruments & Lenses
SPAISafe Pro Group Inc. Common StockOrthopedic & Prosthetic Devices
GEOSGeospace Technologies Corporation Common StockMeasuring & Controlling Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.3

Strong Buy

Consensus rating

52-Week Range

Low$4.95

High$12.94